Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors

被引:0
作者
Mei Tian
Hong Zhang
Noboru Oriuchi
Tetsuya Higuchi
Keigo Endo
机构
[1] Gunma University School of Medicine,Department of Nuclear Medicine and Diagnostic Radiology
[2] National Institute of Radiological Sciences,Department of Medical Imaging, Research Center for Charged Particle Therapy
来源
European Journal of Nuclear Medicine and Molecular Imaging | 2004年 / 31卷
关键词
Choline; FDG; PET; Oncology; Detection;
D O I
暂无
中图分类号
学科分类号
摘要
We prospectively assessed and compared the usefulness of 11C-choline positron emission tomography (PET) with that of [18F]-2-fluoro-2-deoxy-d-glucose (FDG) PET for the differentiation between benign and malignant tumors. A total of 126 patients with 130 lesions were studied (25 brain tumors, 51 head and neck tumors, 15 bone tumors, 16 lung tumors, and 23 soft tissue tumors). 11C-choline PET and FDG PET were performed from 5 and 40 min, respectively, after injection of 275–370 MBq tracer. PET data were evaluated using the standardized uptake value (SUV) and were analyzed in accordance with the pathologic data. The 11C-choline uptake in malignancies was 3.9±2.3 (n=81), which was significantly higher than that in benign lesions (n=49) (2.6±1.7, P<0.005). The FDG uptake in malignancies was 5.9±3.8 (n=81) and was also significantly higher than that in benign lesions (2.8±2.0, P<0.0001). The 11C-choline uptake in the lesions correlated with FDG uptake (r=0.65, P<0.003). According to an ROC analysis, the areas under the ROC curves (AUCs) for 11C-choline PET were more than 0.8 in bone, head and neck, lung, and soft tissue tumors, while the AUC was 0.79 in brain tumors. The AUCs for FDG PET were similarly more than 0.8 in bone, head and neck, lung, and soft tissue tumors, but had a lower value of 0.585 in brain tumors. In brain, head and neck, bone, and soft tissue tumors, 11C-choline showed higher contrast than FDG. In conclusion, it is feasible to use 11C-choline PET for differentiation between malignant and benign tumours, especially of the brain, head and neck, bone, and soft tissue. However, attention needs to be drawn to the high uptake of 11C-choline in some benign tumors and tumour-like lesions, as this will be of significance in clinical practice.
引用
收藏
页码:1064 / 1072
页数:8
相关论文
共 41 条
  • [1] Smith M(1998)Expression of Glut-1 and Glut-3 in untreated oral squamous cell carcinoma compared with FDG accumulation in a PET study Nucl Med Commun 19 97-12
  • [2] Gallagher H(1978)Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET J Nucl Med 19 1154-1056
  • [3] DeGrado Y(2001)Kinetics of choline transport and phosphorylation in human breast cancer cells: NMR applications of the zero trans method Cancer Res 611 110-1380
  • [4] Effert K(1996)undefined J Urol 155 994-undefined
  • [5] Hara K(1997)undefined J Nucl Med 38 842-undefined
  • [6] Hobson T(1997)undefined Arch Oral Biol 42 497-undefined
  • [7] Hara T(2002)undefined Mol Imaging Biol 4 267-undefined
  • [8] Hara M(2000)undefined J Nucl Med 41 1507-undefined
  • [9] Gauthier H(1985)undefined Can J Neurol Sci 12 214-undefined
  • [10] Zhang E(2001)undefined Nucl Med Commun 22 305-undefined